marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-12-2024
TherapeuticsMD Financial Ratios 2011-2024 | TXMD
Annual Financial Ratios TherapeuticsMD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.3 | 0.3 | -0.7 | -2.5 | -3.3 | -8.6 | -16.5 | -12.3 | -14.6 | -11.2 | -30.3 | -8.4 | -9.9 |
P/S |
18.4 | 0.5 | 46.4 | 6.9 | 11.8 | 71.1 | 75.5 | 57.2 | 61.5 | 40.5 | 98.0 | 77.0 | 61.4 |
EPS |
-1.0 | 12.4 | -21.7 | -0.7 | -0.7 | -0.6 | -0.4 | -0.5 | -0.5 | -0.4 | -0.2 | -0.4 | -0.2 |
EV (Enterprise Value) |
33.6 M | 49.4 M | 318 M | 675 M | 680 M | 1.1 B | 1.15 B | 991 M | 1.18 B | 567 M | 813 M | 300 M | 131 M |
EBITDA per Share |
-0.73 | 0.26 | -9.9 | -0.567 | -0.611 | -0.577 | -0.377 | -0.46 | -0.492 | -0.361 | -0.202 | -0.176 | -0.0859 |
EV/EBITDA |
-45.5 | -3.9 | -4.1 | -8.1 | -14.7 | -10.8 | -13.8 | -10.3 | -31.3 | -18.4 | -24.2 | ||
PEG |
-0.01 | 0.0 | -0.0 | -0.35 | 0.15 | 0.15 | -0.84 | -2.01 | 0.4 | 0.18 | -0.72 | 0.1 | -0.1 |
P/B |
0.8 | 0.9 | -1.3 | -3.6 | 63.5 | 11.7 | 9.7 | 8.7 | 19.6 | 12.6 | 15.7 | -205.2 | -74.9 |
P/CF |
- | - | - | -2.8 | -3.1 | -8.9 | -16.4 | -15.7 | -15.5 | -13.2 | -40.5 | -22.6 | -25.6 |
ROE % |
-35.09 | 318.69 | 184.16 | 148.00 | -1914.39 | -135.98 | -59.21 | -70.50 | -134.91 | -112.04 | -51.96 | 2450.60 | 754.35 |
ROA % |
-23.73 | 123.81 | -101.74 | -101.05 | -66.22 | -62.56 | -53.71 | -63.08 | -115.39 | -91.77 | -45.83 | -603.64 | -897.56 |
ROCE % |
-29.10 | 3.39 | 85.00 | -127.11 | -70.99 | -76.19 | -59.76 | -70.79 | -135.09 | -111.68 | -47.18 | -700.25 | 317.04 |
Current Ratio |
3.1 | 1.6 | 0.6 | 2.2 | 3.9 | 4.5 | 10.5 | 9.3 | 6.6 | 5.3 | 8.1 | 1.3 | 0.4 |
DSO |
- | - | 2296.8 | 182.2 | 179.4 | 250.8 | 94.2 | 84.9 | 55.3 | 58.4 | 80.7 | 58.0 | 4.7 |
DIO |
- | - | 1040.5 | 182.6 | 683.4 | 435.7 | 205.6 | 93.9 | 55.9 | 117.5 | 194.4 | 437.3 | 226.6 |
DPO |
- | 723.1 | 3181.6 | 481.4 | 1105.2 | 3032.3 | 567.2 | 641.7 | 253.2 | 629.0 | 393.8 | 444.4 | 118.1 |
Operating Cycle |
- | - | 3337.3 | 364.8 | 862.8 | 686.5 | 299.8 | 178.7 | 111.2 | 175.9 | 275.1 | 495.3 | 231.3 |
Cash Conversion Cycle |
- | -723.1 | 155.7 | -116.6 | -242.5 | -2345.8 | -267.4 | -462.9 | -142.0 | -453.0 | -118.7 | 50.9 | 113.2 |
All numbers in USD currency
Quarterly Financial Ratios TherapeuticsMD
| 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.09 | - | -0.32 | -0.24 | -0.37 | - | -3.13 | 12.83 | -5.7 | -0.1 | -5.62 | -5.41 | -5.67 | -0.15 | -0.12 | -0.19 | -0.21 | -0.19 | -0.13 | -0.23 | -0.16 | -0.17 | -0.16 | -0.15 | -0.11 | -0.1 | -0.07 | -0.1 | -0.11 | -0.12 | -0.13 | -0.11 | -0.11 | -0.1 | -0.11 | -0.16 | -0.13 | -0.1 | -0.12 | -0.07 | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 | -0.06 | -0.04 | -0.14 | -0.16 | - | -0.03 | -0.02 | -0.01 |
EBITDA per Share |
-0.2 | - | - | -0.23 | -0.27 | - | -1.55 | -1.68 | -2.04 | -4.12 | -4.36 | -4.2 | -4.07 | -0.12 | -0.09 | -0.16 | -0.18 | - | -0.11 | -0.17 | -0.16 | - | -0.15 | -0.15 | -0.11 | - | -0.07 | -0.1 | -0.11 | - | -0.13 | -0.11 | -0.11 | - | -0.11 | -0.16 | -0.13 | - | -0.12 | -0.08 | -0.06 | - | -0.05 | -0.04 | -0.05 | - | -0.04 | -0.05 | -0.03 | - | -0.02 | -0.02 | -0.01 |
ROE % |
-35.76 | -31.03 | 28.97 | 101.02 | -322.00 | -335.88 | -289.99 | -267.33 | 250.34 | 630.99 | 619.05 | 562.67 | 517.68 | 148.00 | -423.22 | -796.94 | -1439.19 | -1914.39 | -1417.51 | -1106.59 | -540.32 | -135.98 | -112.09 | -86.87 | -67.95 | -59.21 | -60.63 | -68.97 | -70.37 | -70.50 | -80.31 | -91.56 | -118.19 | -134.91 | -140.88 | -146.85 | -126.20 | -112.04 | -78.37 | -41.53 | -19.02 | -0.05 | 0.36 | 0.67 | 1.51 | 2.45 | 88.90 | 175.46 | 236.92 | 194.38 | 86.85 | 62.29 | 45.24 |
ROA % |
-20.59 | -17.23 | -38.86 | -53.80 | 27.49 | 18.42 | -6.93 | -7.92 | -104.98 | -84.68 | -82.51 | -77.84 | -86.21 | -101.05 | -96.47 | -90.53 | -82.67 | -66.22 | -66.22 | -71.00 | -65.90 | -62.56 | -58.94 | -52.38 | -50.45 | -53.71 | -54.78 | -62.10 | -63.16 | -63.08 | -70.77 | -79.62 | -101.74 | -115.39 | -119.27 | -123.05 | -104.57 | -91.77 | -64.19 | -34.02 | -15.58 | -0.05 | -0.13 | -0.19 | -0.38 | -0.60 | -103.84 | -207.11 | -281.03 | -231.28 | -103.34 | -74.12 | -53.82 |
ROCE % |
- | - | 30.08 | 60.16 | 117.15 | 99.79 | 137.59 | 177.11 | 191.80 | 487.99 | 421.91 | 331.84 | 225.28 | -123.34 | -107.77 | -100.01 | -84.69 | -50.15 | -70.27 | -77.68 | -77.48 | -64.81 | -76.23 | -67.53 | -63.44 | -43.07 | -62.78 | -71.07 | -72.44 | -52.80 | -83.73 | -94.94 | -121.52 | -107.32 | -144.21 | -150.16 | -129.53 | -77.96 | -91.19 | -67.54 | -55.23 | -32.54 | -202.11 | -358.46 | -520.54 | -466.29 | -381.93 | -127.98 | 105.75 | 190.82 | 84.37 | 61.38 | 45.06 |
Current Ratio |
3.2 | 3.1 | 2.2 | 2.4 | 2.2 | 1.6 | 0.7 | 0.8 | 0.5 | 0.6 | 0.8 | 0.8 | 1.0 | 0.6 | 0.6 | 0.6 | 0.6 | 1.0 | 1.0 | 1.0 | 1.0 | 1.9 | 1.9 | 1.9 | 1.9 | 10.8 | 10.8 | 10.8 | - | - | 11.4 | 15.3 | - | 6.9 | 5.7 | 6.9 | 6.3 | 5.5 | - | 5.5 | 5.5 | 8.5 | 9.7 | 13.5 | 8.5 | 0.8 | 0.8 | 0.8 | 0.8 | 0.5 | 0.5 | 0.5 | 0.5 |
DSO |
- | - | - | - | - | - | 10047.9 | 10648.1 | 4699.6 | 179.7 | 127.3 | 133.3 | 151.8 | 130.9 | 152.8 | 276.1 | 211.4 | 140.0 | 93.8 | 366.2 | 409.9 | 198.4 | 290.6 | 268.3 | 186.1 | 95.8 | 89.4 | 92.9 | 101.1 | 91.5 | 74.2 | 93.3 | 69.9 | 49.4 | 53.6 | 57.4 | 53.1 | 46.2 | 47.0 | 52.4 | 62.0 | 53887.9 | 67.2 | 74.1 | 71.4 | 48568.6 | 53.4 | 67.6 | 40.0 | - | 4.5 | 4.8 | - |
DIO |
- | - | - | - | - | - | 1656.3 | 1981.9 | 1089.0 | - | 129.0 | 164.7 | 149.3 | - | 222.4 | 165.8 | 333.6 | - | 749.4 | 866.6 | 904.8 | - | 426.5 | 656.5 | 342.2 | - | 193.4 | 198.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | 3526.4 | 4553.4 | 2696.2 | - | 295.0 | 274.7 | 305.4 | - | 586.3 | 436.9 | 676.4 | - | 1211.8 | 1401.5 | 2507.6 | - | 2968.6 | 4569.7 | 1932.8 | - | 533.5 | 548.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 11704.2 | 12630.0 | 5788.7 | 179.7 | 256.3 | 298.0 | 301.1 | 130.9 | 375.2 | 441.9 | 545.1 | 140.0 | 843.2 | 1232.8 | 1314.7 | 198.4 | 717.1 | 924.8 | 528.4 | 95.8 | 282.8 | 291.8 | 101.1 | 91.5 | 74.2 | 93.3 | 69.9 | 49.4 | 53.6 | 57.4 | 53.1 | 46.2 | 47.0 | 52.4 | 62.0 | 53887.9 | 67.2 | 74.1 | 71.4 | 48568.6 | 53.4 | 67.6 | 40.0 | - | 4.5 | 4.8 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 8177.8 | 8076.5 | 3092.5 | 179.7 | -38.7 | 23.4 | -4.3 | 130.9 | -211.1 | 5.0 | -131.3 | 140.0 | -368.6 | -168.7 | -1192.8 | 198.4 | -2251.4 | -3644.9 | -1404.4 | 95.8 | -250.7 | -256.7 | 101.1 | 91.5 | 74.2 | 93.3 | 69.9 | 49.4 | 53.6 | 57.4 | 53.1 | 46.2 | 47.0 | 52.4 | 62.0 | 53887.9 | 67.2 | 74.1 | 71.4 | 48568.6 | 53.4 | 67.6 | 40.0 | - | 4.5 | 4.8 | - |
All numbers in USD currency